ATAI Life Sciences N.V.·4/A

Mar 4, 3:49 PM ET

Gutierrez-Esteinou Rolando 4/A

4/A · ATAI Life Sciences N.V. · Filed Mar 4, 2022

Insider Transaction Report

Form 4/AAmended
Period: 2021-12-24
Gutierrez-Esteinou Rolando
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2021-12-24+00 total
    Common Shares (0 underlying)
Footnotes (1)
  • [F1]On December 28, 2021, a Form 4 was inadvertently filed reporting a stock option award to purchase 325,000 common shares that did not in fact occur.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION